Associate Director, Launch Excellence
Revolution Medicines
Summary
Help build the launch excellence capability that enables Revolution Medicines to prepare for and execute global product launches with consistency, visibility, and discipline. Manage assigned launches while supporting the design, implementation, and continuous improvement of the company's global launch management approach within Global Commercialization Effectiveness & Operations.
Job description
The Opportunity
Help build the launch excellence capability that enables Revolution Medicines to prepare for and execute global product launches with consistency, visibility, and discipline. Manage assigned launches while supporting the design, implementation, and continuous improvement of the company's global launch management approach within Global Commercialization Effectiveness & Operations.
What You'll Do
- Lead end-to-end project management for assigned global product launches, from approximately T-24 months through six months post-launch.
- Support the Global Launch Strategy Team for assigned assets, establishing clear governance, operating rhythms, decision-making forums, and accountability across launch workstreams.
- Build, maintain, and drive execution against integrated launch plans that bring together Commercial, Medical, Market Access, Regulatory, Supply, Legal, Finance, Development, and regional stakeholders.
- Manage launch milestones, critical paths, workstream deliverables, interdependencies, risks, issues, and key decisions; develop practical mitigation plans and escalate issues as appropriate.
- Create and maintain launch-readiness assessments, dashboards, timelines, and executive-level reporting that provide transparent, actionable views of assigned launch status and health.
- Partner with the Launch Excellence team to design and implement the global launch-excellence framework, including launch lifecycle standards, readiness criteria, governance, templates, tools, and operating rhythms.
- Lead defined launch-excellence workstreams and capability-building initiatives, from problem definition through implementation, adoption, and continuous improvement.
- Support the development and maintenance of standardized launch-readiness processes, integrated milestone frameworks, dashboards, and reporting that enable consistent visibility across priority launches.
- Coordinate portfolio-level launch status, health, risks, dependencies, and key decisions in partnership with the Launch Excellence and Commercial Project Management leaders.
- Prepare and facilitate launch-readiness reviews, governance forums, and working sessions for assigned launches and portfolio-level priorities; document decisions, actions, risks, and follow-up needed to keep work moving.
- Work with cross-functional teams across Commercial, Medical, Market Access, Regulatory, Supply, Legal, Finance, Development, and regions to embed launch-excellence standards into day-to-day planning and execution.
- Partner with enterprise Project Managers to apply launch-management tools, readiness assessments, and best practices across assets and to share practical problem-solving approaches.
- Identify recurring gaps, process friction, and risks across launches; develop practical recommendations and improvement plans with the relevant stakeholders.
- Capture launch learnings and post-launch insights and translate them into updates to launch methodology, tools, and training materials.
- Contribute to onboarding, training, and change-management activities that strengthen launch-management capability across global and regional teams.
- Develop clear executive-ready materials that communicate launch portfolio status, emerging risks, readiness themes, and recommendations.
Who You Are
A strong commercial launch, project, and program leader who can move comfortably between direct execution for an individual asset and portfolio-level capability building. You bring structure to ambiguity, create momentum across cross-functional teams, and turn launch lessons into practical, repeatable processes. You build trusted partnerships, influence without authority, and communicate clearly with senior leaders and working teams.
Requirements
- Bachelor's degree with 8+ years of relevant experience in biotechnology, pharmaceuticals, healthcare, or a related industry
- Experience leading complex, cross-functional commercialization, launch-readiness, operational-excellence, or business-critical initiatives
- Demonstrated experience managing or supporting product-launch planning, readiness, and execution within a global pharmaceutical or biotechnology organization
- Strong project-management skills, including integrated planning, milestone and dependency management, risk and issue management, governance, and executive communication
- Ability to develop practical processes, tools, and reporting that enable teams to plan, track, and execute work consistently
- Experience working across global and regional operating models and with geographically dispersed stakeholders
- Demonstrated ability to influence without authority and drive alignment across diverse stakeholder groups
- Strong analytical and communication skills, with the ability to synthesize complex information into clear status updates, recommendations, and action plans
- Track record of thriving in a fast-paced, evolving environment with a proactive, collaborative, and solutions-oriented mindset
- Excellent facilitation, interpersonal, organizational, and attention-to-detail skills
- Preferred: Advanced degree such as an MBA, MS, PhD, or equivalent
- Preferred: Oncology or specialty-pharma commercialization experience
- Preferred: Experience contributing to the development of launch-excellence, commercial-operations, or project-management capabilities
- Preferred: Experience supporting launches across multiple markets, regions, or indications
- Preferred: Formal project-management training or certification, such as PMP
Benefits
- Competitive cash compensation
- Equity awards
- Health benefits
- Learning and development opportunities
Company overview
Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies for RAS-addicted cancers. The company is pioneering a new class of therapeutics that target oncogenic RAS mutations, which are among the most common drivers of human cancers. Revolution Medicines employs a unique approach to drug discovery, leveraging deep insights into RAS biology to develop small molecule inhibitors that can address previously undruggable targets. Their pipeline includes multiple clinical-stage candidates designed to inhibit various RAS pathway mutations, with a particular focus on KRAS G12C and other RAS variants. The company's scientific platform combines structural biology, medicinal chemistry, and computational approaches to design highly selective inhibitors. Revolution Medicines aims to transform cancer treatment by developing therapies that can overcome resistance mechanisms and provide durable clinical benefits for patients with RAS-driven malignancies. Their research represents a significant advancement in the field of targeted cancer therapy, addressing one of the most challenging areas in oncology drug development.